Cardiac Marker Measurement by Point-of-Care Testing
Author:
Collinson Paul O.
Reference64 articles.
1. Anon. Seynge of Urynes. London: R. Kele, 1552.
2. Zarling EJ, Sexton H, Milnor P Jr. Failure to diagnose acute myocardial infarction. The clinicopathologic experience at a large community hospital. JAMA 1983; 250: 1177–1181.
3. Topol EJ, Bates ER, Walton JA Jr, et al. Community hospital administration of intravenous tissue plasminogen activator in acute myocardial infarction: improved timing, thrombolytic efficacy and ventricular function. J Am Coll Cardiol 1987; 10: 1173–1177.
4. Yusuf S, Pearson M, Sterry H, et al. The entry ECG in the early diagnosis and prognostic stratification of patients with suspected acute myocardial infarction. Eur Heart J 1984; 5: 690–696.
5. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Fibrinolytic Therapy Trialists’ (FTT) Collaborative Group (published erratum appears in Lancet 1994 Mar 19;343[8899]:742) (see comments). Lancet 1994;343: 311–322.